Articles

The “world’s fattest mice” can overeat without developing insulin resistance or diabetes thanks to a glut of a key hormone, a dichotomy that helps explain why not all obese people are diabetic, a UT Southwestern Medical Center researcher has found.

The reported failure of vitamin E to prevent heart attacks may be due to underdosing, according to a new study by investigators at Vanderbilt University Medical Center.

Diabetic patients undergoing heart bypass surgery can markedly reduce their risk of serious complications by keeping their blood sugar levels in check before the operation.

The glycemic load of a diet influences the risk of cardiovascular disease (CVD), particularly in people who are overweight and obese.

Women who had gestational diabetes when pregnant may be at greater risk of developing pancreatic cancer, according to U.S. and Israeli researchers who said the study was the first to link the two diseases.

From angina to severe heart attacks, the death rate is higher than for non-diabetics. 8.5 percent of people with diabetes who have severe heart attacks die within 30 days, compared to 5.4 percent of those who do not have diabetes.

From the American Heart Association and the American college of sports medicine, comes new recommendations for physical activity, which also includes resistance exercise. These recommendations are not just for patients, but for medical professionals as well. 

CombinatoRx, Incorporated today announced that it has dosed the first patient in a Phase 2a proof of concept clinical trial in Type 2 diabetes with CRx-401, a novel insulin sensitizer designed to provide anti-diabetic activity without promoting weight gain

U.S. black and Hispanic men are now no more likely than whites to have undiagnosed diabetes, researchers say — suggesting that recent prevention and education efforts are paying off for these hard-hit groups.

Angiotensin-converting enzyme inhibitors that cross the blood-brain barrier slow mental decline by about 50% relative to the decline seen in patients on other antihypertensives, according to an observational study of 1,074 hypertensive subjects followed for a median of 6 years.